Skip to main content
. 2023 Apr 29;9(6):515–525. doi: 10.1093/ehjcvp/pvad031

Graphical Abstract.

Graphical Abstract

Summary of study enrollment, assessments, and outcomes. Randomized patients had cardiovascular magnetic resonance imaging (CMR) pre- and 72 (63–122) days post-anthracycline initiation / 22 (13–27) days post last dose of anthracycline. The stethoscopes and blood tubes reflect repeated clinical and biomarker assessment after every anthracycline cycle.